Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Jun 6, 2017
SEATTLE, June 06, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its previously announced underwritten public offering of 3,450,000 shares of its common stock at a price of $16.75 per share, which in...
Jun 1, 2017
SEATTLE, June 01, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an underwritten public offering of 3,000,000 shares of its common stock at a price of $16.75 per share pursuant to its existing shelf ...
May 31, 2017
SEATTLE, May 31, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an agreement to sell 2,750,000 shares of its common stock to Robert W. Baird & Co. Incorporated as the underwriter in an underwritten public offering ...
May 30, 2017
SEATTLE, May 30, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it will webcast the company's presentation at the 2017 Jefferies Healthcare Conference in New York City, on Wednesday, June 7, 2017. The web...
May 25, 2017
More than 35 Abstracts Demonstrate the Value of the nCounter Platform for Targeted Discovery, Biomarker Development and Diagnostic Applications in Cancer Research and Immuno-Oncology NanoString's New Digital Spatial Profiling Technology Featured in Two Abstracts SEATTLE, May 25, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ...
May 10, 2017
SEATTLE, May 10, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Elisha W. Finney, former executive vice president and chief financial officer at Varian Medical Systems (NYSE: VAR), to its Board o...
May 4, 2017
SEATTLE, May 04, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter of 2017. First Quarter Financial Highlights Total revenue of $18.1 million, 23% year-over-year growthTota...
Apr 5, 2017
SEATTLE, April 05, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release first quarter 2017 financial results after the close of trading on Thursday, May 4, 2017. Company management will host...
Apr 3, 2017
WASHINGTON, April 03, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today highlighted the validation of its novel Digital Spatial Profiling (DSP) technology by the current state-of-the-art AQUA® method for quantitating prote...
Mar 29, 2017
SEATTLE, March 29, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, is releasing multiple new products at the American Association of Cancer Research (AACR) Meeting. The new products build on NanoString's existing portfolio of produ...
Mar 27, 2017
SEATTLE, March 27, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the upcoming presentation of recent research in precision oncology and predictive biomarkers using the nCounter® Analysis System. More than 45 ...
Mar 23, 2017
SEATTLE, March 23, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial launch of nCounter® PlexSet™ reagents at the Association of Biomolecular Resource Facilities (ABRF) conference in San Dieg...
Mar 1, 2017
SEATTLE, March 01, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the fourth quarter and year ended December 31, 2016. Fourth Quarter Financial Highlights Total revenue of $25.2 million, ...
Feb 27, 2017
ORLANDO, Fla., Feb. 27, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today highlighted a novel approach to profiling immuno-oncology protein targets through digital quantification using the nCounter® Analysis System. The da...
Feb 24, 2017
SEATTLE, Feb. 24, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release fourth quarter and fiscal year 2016 financial results after the close of trading on Wednesday, March 1, 2017. Company m...
Page:
...
Next Last
 
= add release to Briefcase